AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8608752 — intervention group
Group type: COMPARATOR
Intervention: 16-bit color images
Number of subjects: 11
Study 8608752 — intervention group
Group type: COMPARATOR
Intervention: 8-bit color images
Number of subjects: 11
Study 2534170 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of cefotaxime during resection and another 1 g dose when the bladder catheter was removed
Number of subjects: 50
Study 2534170 — intervention group
Group type: COMPARATOR
Intervention: no additional cefotaxime dose when the bladder catheter was removed
Number of subjects: 50
Study 5801347 — intervention group
Group type: EXPERIMENTAL
Intervention: Elema‐Schonander electrodes
Number of subjects: 8
Study 5801347 — intervention group
Group type: EXPERIMENTAL
Intervention: Dracard electrodes
Number of subjects: 8
Study 5801347 — intervention group
Group type: EXPERIMENTAL
Intervention: Smith and Nephew electrodes
Number of subjects: 8
Study 31634980 — intervention group
Group type: EXPERIMENTAL
Intervention: QSAR model for predicting acute toxicity (LC50) of pesticides
Number of subjects: 0
Study 28432007 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml orange-flavored beverage (0 kcal vs. 200 kcal)
Number of subjects: 0
Study 28432007 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml water (0 kcal) vs. 200 ml strawberry milkshake (200 kcal)
Number of subjects: 0
Study 28432007 — intervention group
Group type: COMPARATOR
Intervention: Overweight/obese children
Number of subjects: 0
Study 28432007 — intervention group
Group type: COMPARATOR
Intervention: Obese/overweight children
Number of subjects: 0
Study 25544403 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 36
Study 23895363 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Interviewing (BMI)
Number of subjects: 180
Study 23895363 — intervention group
Group type: COMPARATOR
Intervention: Control Intervention (CTL)
Number of subjects: 180
Study 22129569 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) cilostazol 200 mg × 1 tablet, once daily
Number of subjects: 92
Study 22129569 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release (IR) cilostazol 100 mg × 2 tablets, BID
Number of subjects: 92
Study 22129569 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) cilostazol 200 mg × 1 tablet, once daily (fed state)
Number of subjects: 92
Study 22129569 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of SR and IR formulations for 8 consecutive days
Number of subjects: 92
Study 19189982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 10 mg h(‐1) at 0.5% concentration with sufentanil 2.6 microg h(‐1)
Number of subjects: 150
Study 19189982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 10 mg h(‐1) at 0.25% concentration with sufentanil 2.6 microg h(‐1)
Number of subjects: 150
Study 19189982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 10 mg h(‐1) at 0.15% concentration with sufentanil 2.6 microg h(‐1)
Number of subjects: 150
Study 17491176 — intervention group
Group type: EXPERIMENTAL
Intervention: Web‐based tailored behavioral smoking cessation materials
Number of subjects: 3971
Study 17491176 — intervention group
Group type: COMPARATOR
Intervention: Web‐based nontailored materials
Number of subjects: 3971
Study 15648962 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral norfloxacin (n = 25)
Number of subjects: 46
Study 15648962 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ampicillin and sulbactam (n = 21)
Number of subjects: 46
Study 15648962 — intervention group
Group type: COMPARATOR
Intervention: Control group (cirrhosis patients hospitalized for other reasons)
Number of subjects: 46
Study 15648962 — intervention group
Group type: EXPERIMENTAL
Intervention: Throat swab culture
Number of subjects: 46
Study 11703222 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine 5 mg once daily
Number of subjects: 346
Study 11703222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study 9164913 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0
Study 9164913 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid
Number of subjects: 0
Study 9164913 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pravastatin and nicotinic acid
Number of subjects: 0
Study 8435884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (4 g four times per day)
Number of subjects: 15
Study 8435884 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 g four times per day)
Number of subjects: 15
Study 3316058 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidazole salicylate (750 mg t.i.d.)
Number of subjects: 0
Study 3316058 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (400 mg t.i.d.)
Number of subjects: 0
Study 28827188 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine-containing treatment (ATX)
Number of subjects: 188
Study 28827188 — intervention group
Group type: COMPARATOR
Intervention: Control (AT)
Number of subjects: 188
Study 27256087 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based education (SBE) training for the Safe Recovery program
Number of subjects: 0
Study 24615657 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 100 mg
Number of subjects: 0
Study 24615657 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 800 mg
Number of subjects: 0
Study 24615657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24615657 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 0
Study 22430688 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-B mouthrinse (OB)
Number of subjects: 60
Study 22430688 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine mouthrinse (LN)
Number of subjects: 60
Study 22430688 — intervention group
Group type: EXPERIMENTAL
Intervention: Rembrandt Plus mouthrinse (RM)
Number of subjects: 60
Study 22430688 — intervention group
Group type: EXPERIMENTAL
Intervention: Excite adhesive system (EX)
Number of subjects: 60
Study 22430688 — intervention group
Group type: COMPARATOR
Intervention: Clearfil SE Bond adhesive system (CSE)
Number of subjects: 60
Study 21176626 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (coronary angiography ≤ 24 hours after randomization)
Number of subjects: 815
Study 21176626 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (coronary angiography ≥ 36 hours after randomization)
Number of subjects: 815
Study 21176626 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 815
Study 21176626 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention
Number of subjects: 815
Study 18480691 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine (50 mg)
Number of subjects: 276
Study 18480691 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine XR (titrated to 150 mg/d)
Number of subjects: 276
Study 18480691 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 276
Study 18480691 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine XR
Number of subjects: 276
Study 16043216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed reminder (minimum group)
Number of subjects: 1558
Study 16043216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed thank you card, newsletters, and reminder (maximum group)
Number of subjects: 1558
Study 16043216 — intervention group
Group type: COMPARATOR
Intervention: No mailings (control)
Number of subjects: 1558
Study 12154114 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ-123 (ET(A) receptor antagonist)
Number of subjects: 0
Study 12154114 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine (control dilator)
Number of subjects: 0
Study 12154114 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 10404920 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention combining increased daytime physical activity (14 weeks) plus a nighttime program (5 nights) to decrease noise and sleep-disruptive nursing care practices
Number of subjects: 29
Study 10404920 — intervention group
Group type: COMPARATOR
Intervention: Nighttime program alone (control group)
Number of subjects: 29
Study 7587797 — intervention group
Group type: EXPERIMENTAL
Intervention: fedotozine 30 mg three times a day
Number of subjects: 238
Study 7587797 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 238
Study 2383162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g/d intravenously for 2 weeks
Number of subjects: 60
Study 2383162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 2383162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (after initial placebo treatment)
Number of subjects: 60
Study 2383162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 60
Study 6454249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicloxacillin administration for 6 days per- and postoperatively
Number of subjects: 60
Study 6454249 — intervention group
Group type: COMPARATOR
Intervention: Non-treated patients
Number of subjects: 60
Study 6454249 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved hygienic routines
Number of subjects: 60
Study 29999537 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographic intervention method (taking photos and writing expressively)
Number of subjects: 145
Study 29999537 — intervention group
Group type: COMPARATOR
Intervention: Taking-photos-only control
Number of subjects: 145
Study 29999537 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 145
Study 29258928 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia
Number of subjects: 106
Study 29258928 — intervention group
Group type: COMPARATOR
Intervention: Combined intravenous‐inhalation anesthesia
Number of subjects: 106
Study 29258928 — intervention group
Group type: EXPERIMENTAL
Intervention: FMEP ratio cut-off values of 77.4%
Number of subjects: 106
Study 29258928 — intervention group
Group type: EXPERIMENTAL
Intervention: FMEP ratio cut-off values of 56.9%
Number of subjects: 106
Study 29258928 — intervention group
Group type: EXPERIMENTAL
Intervention: FMEP ratio ≥57%
Number of subjects: 106
Study 27725652 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 92
Study 27725652 — intervention group
Group type: COMPARATOR
Intervention: mNICE diet
Number of subjects: 92
Study 24503517 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPS practice model (VPM)
Number of subjects: 0
Study 22648471 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus of attention (EXF)
Number of subjects: 36
Study 22648471 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 36
Study 22648471 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal focus (INF)
Number of subjects: 36
Study 19438670 — intervention group
Group type: EXPERIMENTAL
Intervention: Neodymium-doped yttrium aluminium garnet (Nd:YAG) laser treatment
Number of subjects: 22
Study 19438670 — intervention group
Group type: COMPARATOR
Intervention: Control sites (not treated with Nd:YAG laser)
Number of subjects: 22
Study 17486027 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated device treatment for 10 minutes (PDE study)
Number of subjects: 55
Study 17486027 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated device treatment for 10 minutes (SS study)
Number of subjects: 55
Study 17486027 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment) in PDE study
Number of subjects: 55
Study 17486027 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment) in SS study
Number of subjects: 55
Study 16382002 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyltestosterone (MT) (1.25 mg/day) combined with percutaneous estradiol (E2) (1 mg/day)
Number of subjects: 37
Study 16382002 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with percutaneous estradiol (E2) (1 mg/day)
Number of subjects: 37
Study 12678188 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings (Kendall Travel Socks) providing 20-30 mm Hg pressure at the ankle
Number of subjects: 150
Study 12678188 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stockings)
Number of subjects: 150
Study 10781751 — intervention group
Group type: COMPARATOR
Intervention: ASA alone
Number of subjects: 36
Study 10781751 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA + ticlopidine
Number of subjects: 36
Study 10781751 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA + cilostazol
Number of subjects: 36
Study 8640706 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant Active Specific Immunotherapy (ASI) with 3 intradermal injections of 10^7 autologous irradiated tumor cells mixed with 10^7 Bacillus Calmette‐Guèrin
Number of subjects: 120
Study 8640706 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonimmunized patients)
Number of subjects: 120
Study 8640706 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant Active Specific Immunotherapy (ASI)
Number of subjects: 120
Study 10149109 — intervention group
Group type: EXPERIMENTAL
Intervention: ioversol-350
Number of subjects: 80
Study 10149109 — intervention group
Group type: COMPARATOR
Intervention: iohexol-350
Number of subjects: 80
Study 6874972 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational Stage Directed Hypnotherapy (RSDH)
Number of subjects: 48
Study 6874972 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis-only treatment
Number of subjects: 48
Study 6874972 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 48
Study 6874972 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 48
Study 30630401 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed care
Number of subjects: 216
Study 30630401 — intervention group
Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 216
Study 30417648 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen immediate-release (IR) tablet
Number of subjects: 17
Study 26477395 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F‐FDG‐PET based workup strategy (PWU)
Number of subjects: 150
Study 26477395 — intervention group
Group type: COMPARATOR
Intervention: Conventional workup strategy (CWU)
Number of subjects: 150
Study 24264638 — intervention group
Group type: EXPERIMENTAL
Intervention: SuperBond‐C&B
Number of subjects: 60
Study 24264638 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F
Number of subjects: 60
Study 24264638 — intervention group
Group type: COMPARATOR
Intervention: Ketac Cem (glass ionomer)
Number of subjects: 60
Study 24264638 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac Cem
Number of subjects: 60
Study 24264638 — intervention group
Group type: EXPERIMENTAL
Intervention: All cement types
Number of subjects: 60
Study 24264638 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 22146754 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.0 mm tip-ring electrode spacing
Number of subjects: 31
Study 22146754 — intervention group
Group type: COMPARATOR
Intervention: 1.1 mm tip-ring electrode spacing
Number of subjects: 31
Study 19158317 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (10 mg daily for 4 weeks)
Number of subjects: 32
Study 19158317 — intervention group
Group type: COMPARATOR
Intervention: Control group (16 hypercholesterolemic patients)
Number of subjects: 32
Study 17685686 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Dynamic Stretch (ADS)
Number of subjects: 18
Study 17685686 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Passive Stretch combined with Active Dynamic Stretch (SADS)
Number of subjects: 18
Study 17685686 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Dynamic Stretch combined with Active Dynamic Stretch (DADS)
Number of subjects: 18
Study 16368585 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lignocaine spray
Number of subjects: 58
Study 16368585 — intervention group
Group type: COMPARATOR
Intervention: 2% lignocaine jelly
Number of subjects: 58
Study 11893233 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release alfuzosin 10mg once daily
Number of subjects: 0
Study 11893233 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release alfuzosin 2.5mg three times daily
Number of subjects: 0
Study 11893233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10442900 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCR gene variants screening in AMD population
Number of subjects: 212
Study 10442900 — intervention group
Group type: COMPARATOR
Intervention: Control group (56 individuals with no known history of AMD)
Number of subjects: 212
Study 8657319 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 301
Study 8657319 — intervention group
Group type: COMPARATOR
Intervention: Intravenous streptokinase
Number of subjects: 301
Study 2138176 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% erythromycin plus 1.2% zinc acetate
Number of subjects: 73
Study 2138176 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 73
Study 7357232 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (conversation training programme)
Number of subjects: 0
Study 7357232 — intervention group
Group type: COMPARATOR
Intervention: Behavioural treatment control
Number of subjects: 0
Study 7357232 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study 31604496 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture Bridge (SB) technique
Number of subjects: 92
Study 31604496 — intervention group
Group type: EXPERIMENTAL
Intervention: Medially Based Single-Row (medSR) technique
Number of subjects: 92
Study 31604496 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SB and medSR techniques
Number of subjects: 92
Study 29166185 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental holding and an upright position
Number of subjects: 34
Study 26188879 — intervention group
Group type: EXPERIMENTAL
Intervention: 25mg etanercept
Number of subjects: 31
Study 26188879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 23388517 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made lipid- and protein-rich nutrition
Number of subjects: 18
Study 23388517 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control nutrition
Number of subjects: 18
Study 21492412 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief alcohol intervention (N=454)
Number of subjects: 908
Study 21492412 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control) (N=454)
Number of subjects: 908
Study 19681767 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acid supplementation for 5 weeks
Number of subjects: 0
Study 19681767 — intervention group
Group type: COMPARATOR
Intervention: Control group (not n-3 supplemented burned group)
Number of subjects: 0
Study 17605771 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary assessment and treatment of multifactorial fall risk factors.
Number of subjects: 100
Study 17605771 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 100
Study 15646610 — intervention group
Group type: EXPERIMENTAL
Intervention: Oraqix anesthetic gel
Number of subjects: 337
Study 15646610 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 337
Study 11438048 — intervention group
Group type: EXPERIMENTAL
Intervention: Tectonic penetrating keratoplasty
Number of subjects: 60
Study 11438048 — intervention group
Group type: EXPERIMENTAL
Intervention: Tectonic sclerokeratoplasty
Number of subjects: 60
Study 11438048 — intervention group
Group type: COMPARATOR
Intervention: Control group (central penetrating keratoplasty for inactive central corneal scars)
Number of subjects: 60
Study 9724256 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg for 21 days
Number of subjects: 0
Study 9724256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7831626 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (BA+CS)
Number of subjects: 141
Study 7831626 — intervention group
Group type: COMPARATOR
Intervention: Anticholinergic (BA+AC)
Number of subjects: 141
Study 7831626 — intervention group
Group type: COMPARATOR
Intervention: Placebo (BA+PL)
Number of subjects: 141
Study 3207566 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine hydrochloride (60 mg)
Number of subjects: 6
Study 3207566 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (50 mg)
Number of subjects: 6
Study 3207566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3207566 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine hydrochloride
Number of subjects: 6
Study 31597460 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen (60/30 mg daily)
Number of subjects: 21105
Study 31597460 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen (30/15 mg daily)
Number of subjects: 21105
Study 31597460 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21105
Study 28240714 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% glycerol solution containing 26 ml·kg of water and 1 g·kg of glycerol
Number of subjects: 7
Study 28240714 — intervention group
Group type: COMPARATOR
Intervention: Control group drinking 26 ml·kg of water
Number of subjects: 7
Study 26378819 — intervention group
Group type: EXPERIMENTAL
Intervention: Main error (ME) correction
Number of subjects: 22
Study 26378819 — intervention group
Group type: COMPARATOR
Intervention: Secondary error (SE) correction
Number of subjects: 22
Study 23562657 — intervention group
Group type: EXPERIMENTAL
Intervention: P-iTBS (sham intermittent theta burst stimulation)
Number of subjects: 26
Study 23562657 — intervention group
Group type: COMPARATOR
Intervention: CON (no intervention)
Number of subjects: 26
Study 23562657 — intervention group
Group type: EXPERIMENTAL
Intervention: P-rTMS (sham high-frequency repetitive TMS)
Number of subjects: 26
Study 22012943 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic music video intervention
Number of subjects: 0
Study 22012943 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment fidelity strategies
Number of subjects: 0